Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve audited financial statement ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chandra Bhagat Pharma Ltd has informed BSE that its Board of Directors will meet on Thursday, 29th May 2025 at 4:00 PM at the registered office in Matunga East, Mumbai. The main item on the agenda is to consider and approve the audited financial statements along with the auditor's report for both the half year and the full year ended 31st March 2025. The company may also discuss other business matters during the meeting. This is a routine regulatory filing under SEBI Listing Regulations to notify the stock exchange ahead of the results announcement.
This is a pre-results intimation and does not contain any financial figures, so there is no immediate impact on shareholders or the stock price. Investors should watch for the actual audited results to be published after 29th May 2025 for any meaningful information on the company's performance.